Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Moonshiner592on Mar 10, 2020 4:58pm
80 Views
Post# 30790332

RE:RE:RE:Enough is enough - Looking4Doubles Blocked

RE:RE:RE:Enough is enough - Looking4Doubles Blocked
Scotty wrote: I agree, anyone making investments based on forum gossip is making a big mistake. That doesn't mean a lot of people don't do exactly that.

Venture stocks are risky by nature, bashing them or pumping them isn't useful for anyone trying to make informed decisions. Doubles is ignoring the blatently obvious for some reason and won't address the issues.

I enjoy tossing around ideas and discussing the facts with other investors. His contributions are worthless imo, like Penny's, so I'm chosing to ignore him.


Double's contributions to the board are "useless"?   .... are you certain of that? ... ouch ...
Bullboard Posts